TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/11/21 06:59 | 6/9/21 | SEER | Seer, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Amoon Growth Fund Limited Partnership | L3 | T | S | -30,000 | 30.00 | 0 | -1,000 | -17 | 4,923 | M | |||||||||||||||
12/10/20 16:15 | 12/8/20 | SEER | Seer, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Amoon 2 Fund Limited Partnership | L3 | T | P.dm | 16,900 | 19.00 | 0 | 889 | 18 | 5,923 | M | |||||||||||||||
5/14/20 16:31 | 5/12/20 | AYLA | Ayala Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Amoon 2 Fund Limited Partnership | L3 | T | P.d | 12,000 | 15.00 | 0 | 800 | 37 | 2,991 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |